NCT05826561

Brief Summary

Underdiagnosis and undertreatment is a major problem in childhood asthma management, especially in preschool-aged children. Current prognostic approaches using risk-score based tools have poor-to-modest accuracy, are impractical, and have limited evidence of efficacy in clinical settings and hence are not widely used in practice. The objective of the study is to determine the usability, acceptability, feasibility, and preliminary efficacy of the childhood asthma passive digital marker (PDM) among pediatricians. The study will include practicing pediatricians within the IU Health Network.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
1.1 years until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2025

Completed
Last Updated

July 8, 2025

Status Verified

July 1, 2025

Enrollment Period

1 year

First QC Date

April 12, 2023

Last Update Submit

July 2, 2025

Conditions

Keywords

Pediatric AsthmaEarly DetectionScreeningPassive Digital MarkerRisk Factors

Outcome Measures

Primary Outcomes (3)

  • Perceived PDM acceptance

    Perceived PDM acceptance will be measured using a Behavioral Intention scale (BIS).

    8 to 12 months

  • Perceived PDM usability

    Perceived Usability will be measured using a modified Simplified System Usability Scale (SUS).

    8 to 12 months

  • Study feasibility

    Percent of successful study enrollment of eligible clinicians (\>80%)

    8 to 12 months

Secondary Outcomes (1)

  • Prognostic accuracy

    3 to 12 months

Study Arms (4)

Control Clinicians - post test only

NO INTERVENTION

N=25 control pediatric clinicians, who will receive the post test only. Each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.

PDM Intervention Clinicians - post test only

EXPERIMENTAL

N=25 intervention pediatric clinicians, who will receive the post test only. Using the PDM, each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.

Other: Childhood Asthma Passive Digital Marker

Control Clinicians - pre and post test

NO INTERVENTION

N=25 control pediatric clinicians, who will receive the pre and post test. Each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.

PDM Intervention Clinicians - pre and post test

ACTIVE COMPARATOR

N=25 intervention pediatric clinicians, who will receive the pre and post test. Using the PDM, each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.

Other: Childhood Asthma Passive Digital Marker

Interventions

A childhood asthma Passive Digital Marker (PDM) is an ML algorithm that is able to retrieve and synthesize pre-existing "passively" collected mother/child dyad prognostic data in "digital" electronic health record (EHR) to provide an objective and quantifiable "marker" of a child's risk (probability) and associated pathophysiological phenotype to inform clinician decision-making at point-of-care.

Also known as: Passive Screening Test (PDM)
PDM Intervention Clinicians - post test onlyPDM Intervention Clinicians - pre and post test

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Practicing pediatricians within the IU Health Network

You may not qualify if:

  • Non-practicing pediatricians within the IU Health Network

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University

Indianapolis, Indiana, 46202, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 12, 2023

First Posted

April 24, 2023

Study Start

June 1, 2024

Primary Completion

June 16, 2025

Study Completion

June 16, 2025

Last Updated

July 8, 2025

Record last verified: 2025-07

Locations